Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Molly Henderson Insider Profile
4 Followers
Molly Henderson, CFO at Iovance Biotherapeutics, holds 0.00 shares in Iovance Biotherapeutics (Ticker: IOVA), holds 97.17K shares in Phathom Pharmaceuticals (Ticker: PHAT), holds 5.25K shares in Urogen Pharma (Ticker: URGN). Most recently, Molly Henderson ― shares of Iovance Biotherapeutics on ― for an estimated value of ―.
Profitable Transactions
2 out of 5 Profitable Transactions
Average Return
-10.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Molly Henderson holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Nov 23, 2022 - Nov 23, 2023
Return:+28.30%
The most profitable trade made by Molly Henderson
Molly Henderson's Trading History
Iovance Biotherapeutics
―
CFO
―
$0.00
Advaxis
Apr 11, 2019
EVP & CFO
Uninformative Buy
9.18K
$3.45K
Urogen Pharma
Feb 02, 2022
CFO
Uninformative Buy
2.51K
$72.53K
Phathom Pharmaceuticals
Apr 10, 2024
CFO and CBO
Informative Sell
38.13K
$877.48K
Virtualscopics
Jun 21, 2012
―
Informative Buy
7.20K
$58.03K
List of latest transactions for each holding click on a transaction to see Molly Henderson's performance on stock
You May Also Like
Molly Henderson insider profile FAQ
What is the percentage of profitable transactions made by Molly Henderson?
The percentage of profitable transactions made by Molly Henderson is 40%.
What is the average return per transaction made by Molly Henderson?
The average return per transaction made by Molly Henderson is -10.10%.
What stocks does Molly Henderson hold?
Molly Henderson holds: IOVA, ADXS, URGN, PHAT, VSCP stocks.
What was Molly Henderson’s latest transaction?
Molly Henderson latest transaction was an Uninformative Buy of ―.
What was Molly Henderson's most profitable transaction?
Molly Henderson’s most profitable transaction was an Informative Sell of PHAT stock on November 23, 2022. The return on the trade was 28.30%.
What is Molly Henderson's role in Iovance Biotherapeutics?
Molly Henderson's role in Iovance Biotherapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.